Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Non-Current Debt (2020 - 2026)

PROCEPT BioRobotics has reported Non-Current Debt over the past 7 years, most recently at $51.7 million for Q1 2026.

  • Quarterly Non-Current Debt changed 0.32% to $51.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $51.7 million through Mar 2026, changed 0.32% year-over-year, with the annual reading at $51.6 million for FY2025, 0.28% changed from the prior year.
  • Non-Current Debt was $51.7 million for Q1 2026 at PROCEPT BioRobotics, roughly flat from $51.6 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $51.7 million in Q1 2026 and troughed at $50.3 million in Q1 2022.
  • The 5-year median for Non-Current Debt is $51.4 million (2024), against an average of $51.3 million.
  • Year-over-year, Non-Current Debt rose 2.42% in 2022 and then rose 0.23% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $51.2 million in 2022, then grew by 0.25% to $51.3 million in 2023, then increased by 0.26% to $51.5 million in 2024, then rose by 0.28% to $51.6 million in 2025, then grew by 0.09% to $51.7 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Non-Current Debt are $51.7 million (Q1 2026), $51.6 million (Q4 2025), and $51.6 million (Q3 2025).